NSE · TATVA
Tatva Chintan Pharma Chem Limited
₹1,717.30
+0.45%
Market Cap
4,017.11 Cr
P/E Ratio
95.51
P/B Ratio
5.14
ROE
5.38%
ROCE
7.57%
Dividend Yield
—
52W High
₹1,838.10
52W Low
₹976.40
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 167.06 Cr | 134.14 Cr |
| Net Profit | 15.98 Cr | 10.32 Cr |
| EPS | 6.83 | 4.41 |
| Operating Profit | 24.51 Cr | 18.02 Cr |
Shareholding pattern
Promoter
72.02%
Public
27.98%
FII
—
DII
—
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 12 Sep 2025 | Dividend | Dividend - Re 1 Per Share |
| 06 Sep 2024 | Dividend | Dividend - Rs 2 Per Share |
| 06 Sep 2024 | Other | Annual General Meeting |
| 08 Sep 2023 | Other | Annual General Meeting |
| 08 Sep 2023 | Dividend | Dividend - Rs 2 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.